Barinthus Biotherapeutics plc (BRNS)

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics had revenue of $14.97M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $14.97M, up 106.21% year-over-year. In the year 2023, Barinthus Biotherapeutics had annual revenue of $802.00K, down -98.21%.

• Revenue (ttm): $14.97M
• Revenue Growth: +106.21%
• P/S Ratio: 2.33
• Revenue / Employee: $115,146
• Employees: 130
• Market Cap: 35.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	802.00K	-43.90M	-98.21%
Dec 31, 2022	44.70M	44.44M	16,580.22%
Dec 31, 2021	268.00K	-4.55M	-94.44%
Dec 31, 2020	4.82M	-2.02M	-29.57%
Dec 31, 2019	6.85M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.